image

The best stocks to buy since 1993

Latest issue now available

Alpha FX - Not yet peak Alpha

April 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • AFX
  • Price:
  • 2040p
If I had to throw my hat in the ring and tell you which one of the present constituents of Growth Portfolio 3 has scope to double the quickest, FX broker Alpha FX might appear an unlikely contender given its lofty share price.  But the latest year just reported saw group revenues up an astonishing 68% to £77.5m and profits before tax up by a blistering 91% to £33.4m despite investing in more staff (headcount up from 147 to 214) and several new overseas offices. The number of companies using its FX services soared from 754 to 958 in FY21 and the average size of new client wins also skyrocketed (leading to average revenue per client increasing 36% in FY21). Put all that together and you have scope for some sizzling share price appre ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe